Exposure to anxiety-eliciting stimuli

Exposure to anxiety-eliciting stimuli refers to a clinical or experimental paradigm where a subject is presented with stressors or cues that evoke fear, apprehension, or psychological distress. It is not a molecular target such as a protein or enzyme, but rather a physiological and psychological challenge used to study the neurobiology of fear and evaluate the efficacy of anxiolytic medications (StatPearls). Biologically, these stimuli activate the 'fear circuit,' primarily involving the amygdala, and trigger the hypothalamic-pituitary-adrenal (HPA) axis, leading to autonomic responses such as increased heart rate and cortisol release (NIH/NCBI). In a therapeutic context, controlled exposure is the cornerstone of 'exposure therapy,' where repeated contact with the stimuli aims to facilitate habituation and extinction learning, a process sometimes augmented by pharmacological agents like D-cycloserine (PubMed). Pharmacological treatments, including benzodiazepines and SSRIs, are often assessed based on their ability to attenuate the acute responses triggered by these stimuli. This paradigm is essential for understanding and treating disorders like Post-Traumatic Stress Disorder (PTSD) and various phobias.

Other names

Anxiety provocationExposure therapyPsychological stressorFear-eliciting stimuliAnxiogenic challenge

Not applicable as a molecular target; however, drugs modulate the response through GABAergic enhancement, serotonergic regulation, or NMDA receptor-mediated extinction enhancement.